Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Myovant Sciences Ltd (NY: MYOV )

N/A UNCHANGED
Last Price Updated: 7:00 PM EST, Mar 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Myovant Sciences Ltd

< Previous 1 2 3 4 5 Next >
The 2 Best Pharma Stocks to Buy on Dips
Because the COVID-19 pandemic is under control in most major economies, the hype surrounding vaccine producers is gradually tapering off. 
Via Talk Markets
Exposures COVID-19
3 Dividend-Paying Pharmaceutical Stocks to Buy This Summer
The pharmaceutical industry has benefited from much investor attention amid the COVID-19 pandemic. 
Via Talk Markets
Exposures COVID-19
Looking Into Myovant Sciences's Return On Capital Employed
During Q4, Myovant Sciences (NYSE:MYOV) brought in sales totaling $24.61 million. However, earnings decreased 1.75%, resulting in a loss of $76.95 million. Myovant Sciences... 
Via Benzinga
Myovant - Pfizer's Uterine Fibroids Treatment Wins FDA Approval
The FDA has approved Myovant Sciences Ltd (NYSE: MYOV) and Pfizer Inc’s (NYSE: PFE) relugolix combined with estradiol and norethindrone acetate for... 
Via Benzinga
Exposures Product Safety
Myovant Sciences' Relugolix Combo Tablet For Uterine Fibroids Scores EMA Backing For Approval
European Medicines Agency's advisory committee issued a positive opinion recommending the approval of Myovant Sciences Ltd's (NYSE: MYOV) Ryeqo (... 
Via Benzinga
Earnings Scheduled For May 11, 2021
Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is... 
Via Benzinga
The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)... 
Via Benzinga
Exposures COVID-19
Myovant Stock Is Trading Lower After FDA Slapped Clinical Hold On Relugolix Combo Study
Myovant Sciences Ltd (NYSE: MYOV) has received a partial clinical hold on its SERENE study (MVT-601-050) from the FDA. The Phase 3 study was evaluating relugolix... 
Via Benzinga
Exposures Product Safety
Myovant Sciences Ltd. (MYOV) Q4 2020 Earnings Call Transcript
MYOV earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
9 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away... 
Via Benzinga
Return On Capital Employed Overview: Myovant Sciences
Myovant Sciences (NYSE:MYOV) reported Q4 sales of $24.61 million. Earnings fell to a loss of $76.95 million, resulting in a 1.75% decrease from last quarter. In Q3, Myovant... 
Via Benzinga
Myovant Sciences: Q4 Earnings Insights
Shares of Myovant Sciences (NYSE:MYOV) moved higher by 4.5% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 21.... 
Via Benzinga
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... 
Via Benzinga
Exposures COVID-19 Product Safety
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Exposures COVID-19 Product Safety
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.